EiPLA

EiPLA, also known as N-ethyl-N-isopropyllysergamide or as lysergic acid ethylisopropylamide, is a psychedelic drug of the lysergamide family related to lysergic [acid diethylamide]. It is an isomer of ETH-LAD.

Pharmacology

Pharmacodynamics

In drug discrimination tests in rodents, EiPLA was found to have approximately half the potency of LSD.

Chemistry

Analogues

Analogues of EiPLA include MiPLA, LAMPA, EPLA, EcPLA, and ETFELA, among others.

History

EiPLA was first described in the scientific literature by David E. Nichols and colleagues by at least 1994. It appears to have emerged as a novel designer drug by 2019.